Arboretum LifeSciences raises $30M Series A+.

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Arboretum LifeSciences raises $30M Series A+ led by Anthony Philippakis.</p><p>Participants in this funding round include notable investors interested in advancing molecular information technologies.</p><p>Arboretum LifeSciences develops a molecular information platform. The company is led by CEO Anthony Philippakis.</p><table class="vc-deal-terms"><tbody><tr><th>Company</th><td>Arboretum LifeSciences</td></tr><tr><th>Round</th><td>Series A+</td></tr><tr><th>Amount</th><td>$30M</td></tr><tr><th>Founders</th><td>Anthony Philippakis</td></tr><tr><th>Sectors</th><td>molecular information</td></tr></tbody></table>
</div>
</div>
</div>


<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Arboretum LifeSciences raises <strong>$30M</strong> Series A+ led by Anthony Philippakis.</p>
<p>Participants in this funding round include notable investors interested in advancing molecular information technologies.</p>
<p>Arboretum LifeSciences develops a molecular information platform. The company is led by CEO Anthony Philippakis.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Arboretum LifeSciences</td>
</tr>
<tr>
<th>Round</th>
<td>Series A+</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$30M</strong></td>
</tr>
<tr>
<th>Founders</th>
<td>Anthony Philippakis</td>
</tr>
<tr>
<th>Sectors</th>
<td>molecular information</td>
</tr>
</tbody></table>
</div>
</div>
</div>


Arboretum Lifesciences Raises $30M Series A+

Arboretum Lifesciences Raises $30M Series A+ | Traded VC

ABOUT THIS STORY

<div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <div style="font-family: 'Poppins', sans-serif; font-size: 20px;">
  <p>Arboretum LifeSciences raises <strong>$30M</strong> Series A+ led by Anthony Philippakis.</p>
<p>Participants in this funding round include notable investors interested in advancing molecular information technologies.</p>
<p>Arboretum LifeSciences develops a molecular information platform. The company is led by CEO Anthony Philippakis.</p>
<table class="vc-deal-terms"><tbody>
<tr>
<th>Company</th>
<td>Arboretum LifeSciences</td>
</tr>
<tr>
<th>Round</th>
<td>Series A+</td>
</tr>
<tr>
<th>Amount</th>
<td><strong>$30M</strong></td>
</tr>
<tr>
<th>Founders</th>
<td>Anthony Philippakis</td>
</tr>
<tr>
<th>Sectors</th>
<td>molecular information</td>
</tr>
</tbody></table>
</div>
</div>
</div>

Arboretum Lifesciences Raises $30M Series A+

ABOUT THIS STORY

Bytexl Raises $9M From Elevar Equity to Expand Its B2b Edtech Platform

Hilt Raises $4.2M

Fortastra Raises $30M From Citi to Scale Its Network

Company	Arboretum LifeSciences
Round	Series A+
Amount	$30M
Founders	Anthony Philippakis
Sectors	molecular information

Arboretum Lifesciences Raises $30M Series A+

ABOUT THIS STORY

More articles

Bytexl Raises $9M From Elevar Equity to Expand Its B2b Edtech Platform

Hilt Raises $4.2M

Fortastra Raises $30M From Citi to Scale Its Network